Zur Kurzanzeige

2019-10-11Zeitschriftenartikel DOI: 10.25646/6549
Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F Employing Taguchi Design-of-Experiments
dc.contributor.authorvon Berg, Laura
dc.contributor.authorStern, Daniel
dc.contributor.authorWeisemann, Jasmin
dc.contributor.authorRummel, Andreas
dc.contributor.authorDorner, Martin Bernhard
dc.contributor.authorDorner, Brigitte Gertrud
dc.date.accessioned2020-03-17T10:22:44Z
dc.date.available2020-03-17T10:22:44Z
dc.date.issued2019-10-11none
dc.identifier.other10.3390/toxins11100588
dc.identifier.urihttp://edoc.rki.de/176904/6518
dc.description.abstractThe detection of catalytically active botulinum neurotoxins (BoNTs) can be achieved by monitoring the enzymatic cleavage of soluble NSF (N-ethylmaleimide-sensitive-factor) attachment protein receptor (SNARE) proteins by the toxins’ light chains (LC) in cleavage-based assays. Thus, for sensitive BoNT detection, optimal cleavage conditions for the clinically relevant A–F serotypes are required. Until now, a systematic evaluation of cleavage conditions for the different BoNT serotypes is still lacking. To address this issue, we optimized cleavage conditions for BoNT/A–F using the Taguchi design-of-experiments (DoE) method. To this aim, we analyzed the influence of buffer composition (pH, Zn2+, DTT (dithiothreitol), NaCl) as well as frequently used additives (BSA (bovine serum albumin), Tween 20, trimethylamine N-oxide (TMAO)) on BoNT substrate cleavage. We identified major critical factors (DTT, Zn2+, TMAO) and were able to increase the catalytic efficiency of BoNT/B, C, E, and F when compared to previously described buffers. Moreover, we designed a single consensus buffer for the optimal cleavage of all tested serotypes. Our optimized buffers are instrumental to increase the sensitivity of cleavage-based assays for BoNT detection. Furthermore, the application of the Taguchi DoE approach shows how the method helps to rationally improve enzymatic assays.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectbotulinum neurotoxinseng
dc.subjectdetectioneng
dc.subjectsubstrate cleavageeng
dc.subjecttaguchi design-of-experimentseng
dc.subjectSNAREeng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleOptimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A–F Employing Taguchi Design-of-Experimentsnone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6518-9
dc.identifier.doihttp://dx.doi.org/10.25646/6549
dc.type.versionpublishedVersionnone
local.edoc.container-titleToxinsnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.mdpi.com/2072-6651/11/10/588none
local.edoc.container-publisher-nameMolecular Diversity Preservation International (MDPI)none
local.edoc.container-volume11none
local.edoc.container-issue10none
local.edoc.container-year2019none
local.edoc.container-firstpage1none
local.edoc.container-lastpage18none
local.edoc.rki-departmentZentrum für Biologische Gefahren und Spezielle Pathogenenone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige